Amanda Laskey

Amanda is a senior manager in the tax services practice in the New York City office of RSM US LLP, focusing on clients within the life sciences industry. In addition, she is a member of the firm’s Industry Eminence Program and works alongside RSM’s chief economist and other senior analysts to understand, forecast and communicate economic, business and technology trends affecting middle market businesses. She has nearly 10 years of experience assisting clients with claiming research and development tax credits at both the federal and state levels.

5 things to know in life sciences: Week of October 28, 2024

Nov. 1, 2024 by Amanda Laskey and Brian Winne

Spatial transcriptomics is revolutionizing the way researchers map gene expression in tumor and brain samples, providing insights that could change disease treatment. This and more in this week’s update. … READ MORE >

Medtech executives discuss regulatory collaboration, AI, strategic funding and more

Oct. 30, 2024 by Amanda Laskey

What’s on the minds of the world’s top medtech executives? … READ MORE >

5 things to know in life sciences: Week of October 21, 2024

Oct. 25, 2024 by Amanda Laskey and Brian Winne

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >

5 things to know in life sciences: Week of October 14, 2024

Oct. 18, 2024 by Amanda Laskey and Brian Winne

Competition continues to increase in the obesity treatment space. This and more in this week’s life sciences update. … READ MORE >

5 things to know in life sciences: Week of October 7, 2024

Oct. 11, 2024 by Amanda Laskey and Brian Winne

 Each week we highlight five things affecting the life sciences industry. Here’s the latest. FDA approves at-home COVID/flu combo test for fall season The U.S. Food and Drug Administration has approved an at-home test by Healgen that detects both COVID-19 and influenza A and B, marking a significant milestone in … … READ MORE >